These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 2975067
1. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Carlson JH, Bergstrom DA, Weick BG, Walters JR. Synapse; 1987; 1(5):411-6. PubMed ID: 2975067 [Abstract] [Full Text] [Related]
2. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. Huang KX, Walters JR. J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977 [Abstract] [Full Text] [Related]
3. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR, Hu XT, Galloway MP, White FJ. Synapse; 1989 Jan; 4(4):327-46. PubMed ID: 2532422 [Abstract] [Full Text] [Related]
4. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus. Carlson JH, Bergstrom DA, Demo SD, Walters JR. Synapse; 1990 Jan; 5(2):83-93. PubMed ID: 2309160 [Abstract] [Full Text] [Related]
5. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG, Walters JR. Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219 [Abstract] [Full Text] [Related]
6. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. Huang KX, Walters JR. J Pharmacol Exp Ther; 1994 Dec 10; 271(3):1434-43. PubMed ID: 7996456 [Abstract] [Full Text] [Related]
7. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393. Ruskin DN, Rawji SS, Walters JR. J Pharmacol Exp Ther; 1998 Jul 10; 286(1):272-81. PubMed ID: 9655869 [Abstract] [Full Text] [Related]
8. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons. Kelland MD, Freeman AS, Chiodo LA. Synapse; 1988 Jul 10; 2(4):416-23. PubMed ID: 2973142 [Abstract] [Full Text] [Related]
9. Neurotensin-dopamine interactions in the substantia nigra of the rat brain. Merchant KM, Bush LG, Gibb JW, Hanson GR. J Pharmacol Exp Ther; 1990 Nov 10; 255(2):775-80. PubMed ID: 2147039 [Abstract] [Full Text] [Related]
10. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons. Ruskin DN, Bergstrom DA, Walters JR. J Neurophysiol; 2002 Jul 10; 88(1):487-96. PubMed ID: 12091570 [Abstract] [Full Text] [Related]
11. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX, Bergstrom DA, Ruskin DN, Walters JR. Synapse; 1998 Sep 10; 30(1):18-29. PubMed ID: 9704877 [Abstract] [Full Text] [Related]
12. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. Breese GR, Napier TC, Mueller RA. J Pharmacol Exp Ther; 1985 Aug 10; 234(2):447-55. PubMed ID: 3926987 [Abstract] [Full Text] [Related]
13. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L. Synapse; 1990 Aug 10; 5(2):113-9. PubMed ID: 2137942 [Abstract] [Full Text] [Related]
14. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction. Shen RY, Asdourian D, Chiodo LA. Synapse; 1992 Aug 10; 11(4):319-29. PubMed ID: 1354398 [Abstract] [Full Text] [Related]
15. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons. Waszczak BL. Brain Res; 1990 Apr 09; 513(1):125-35. PubMed ID: 2140951 [Abstract] [Full Text] [Related]
16. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus. Bijak M, Danek L, Smiałowski A. Pol J Pharmacol Pharm; 1988 Apr 09; 40(5):535-41. PubMed ID: 2908137 [Abstract] [Full Text] [Related]
17. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. Rosenzweig-Lipson S, Bergman J. J Pharmacol Exp Ther; 1993 Nov 09; 267(2):765-75. PubMed ID: 7902432 [Abstract] [Full Text] [Related]
18. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons. Cox RF, Neumeyer JL, Waszczak BL. J Pharmacol Exp Ther; 1988 Oct 09; 247(1):355-62. PubMed ID: 3171980 [Abstract] [Full Text] [Related]
19. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area. Meltzer LT, Christoffersen CL, Serpa KA, Razmpour A. Synapse; 1993 Feb 09; 13(2):117-22. PubMed ID: 8446920 [Abstract] [Full Text] [Related]
20. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration. Kelland MD, Freeman AS, Chiodo LA. Synapse; 1989 Feb 09; 3(1):30-7. PubMed ID: 2919369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]